Effects of Methotrexate and Tofacitinib on Mitochondrial Function and Oxidative Stress in Human Synovial Cells In Vitro
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26178173 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Valentina Mihaylova und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biology, Medical University, Blvd. Vasil Aprilov 15A, 4000 Plovdiv, Bulgaria. Hauptthemen laut MEDLINE: Oxidative Stress, Pyrimidines, Methotrexate, Piperidines. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University Plovdiv, NextGeneration EU, BBMRI.
Abstract (Originalsprache)
Rheumatoid arthritis (RA) is an autoimmune disease affecting the synovium. Mitochondrial dysfunction is considered a critical factor in the pathogenesis of RA. The aim of the study was to determine the effect of methotrexate and tofacitinib on mitochondrial function and oxidative stress in an in vitro study on the model synovial cell line SW982. TNF-alpha-stimulated SW982 cells, as well as control untreated cells, were incubated with methotrexate and tofacitinib. A metabolic test was performed to assess mitochondrial function. The oxidative stress generated after the application of the therapeutics was determined by a chromatographic analysis. The results obtained showed an increase in ATP levels (p < 0.0001) and a decrease in proton leak (p < 0.0003) after treatment with tofacitinib. The opposite trend was observed—reduced ATP production (p < 0.0096) and increased levels of proton leak (p < 0.0001)—after treatment with methotrexate. A two-fold increase in 8-ISOPGF2A was measured in comparison to TNF-alpha-stimulated and untreated cells. The dynamics of mitochondrial activity and oxidative stress were monitored in a certified RA model cell line after the administration of two different therapeutics. Methotrexate was found to induce mitochondrial dysfunction and oxidative stress in vitro, while tofacitinib partially improved mitochondrial parameters.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Biology, Medical University, Blvd. Vasil Aprilov 15A, 4000 Plovdiv, Bulgaria.
- Research Institute, Medical University, 4002 Plovdiv, Bulgaria.
- Department of Propaedeutics of Internal Diseases, Medical University, 4002 Plovdiv, Bulgaria.
- Clinic of Rheumatology, University Hospital "Kaspela", 4001 Plovdiv, Bulgaria.
ORCID-Profile: Valentina Mihaylova, Desislav Tomov, Anastas Batalov, Victoria Sarafian
Förderung
- Medical University Plovdiv
- NextGeneration EU
- BBMRI
Zitieren
APA
Mihaylova, V., Tomov, D., Karalilova, R., Batalov, Z., Batalov, A., Sarafian, V., & Kazakova, M. (2025). Effects of Methotrexate and Tofacitinib on Mitochondrial Function and Oxidative Stress in Human Synovial Cells In Vitro. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26178173
Vancouver
Mihaylova V, Tomov D, Karalilova R, Batalov Z, Batalov A, Sarafian V, et al. Effects of Methotrexate and Tofacitinib on Mitochondrial Function and Oxidative Stress in Human Synovial Cells In Vitro. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26178173
BibTeX
@article{Mihaylova2025,
author = {Mihaylova, Valentina and Tomov, Desislav and Karalilova, Rositsa and Batalov, Zguro and Batalov, Anastas and Sarafian, Victoria and Kazakova, Maria},
title = {Effects of Methotrexate and Tofacitinib on Mitochondrial Function and Oxidative Stress in Human Synovial Cells In Vitro},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26178173}
}
EUVIMED